Sanofi
SAN
Xếp hạng trong cổ phiếu
#231
Sanofi is a global healthcare enterprise dedicated to the research,... Sanofi is a global healthcare enterprise dedicated to the research, development, manufacturing, and commercialization of therapeutic solutions across the United States, Europe, and other international markets. Its business is structured into three primary divisions: Pharmaceuticals, Vaccines, and Consumer Healthcare. The Pharmaceuticals segment delivers specialized treatments, encompassing human monoclonal antibodies and therapies for a range of conditions such as multiple sclerosis, neurological disorders, various inflammatory and immunological diseases, rare disorders, oncology, and rare blood conditions. This division also provides medications for diabetes, cardiovascular health, and a portfolio of established prescription drugs. Through its Vaccines division, Sanofi supplies crucial immunizations, including pediatric vaccines for diseases like poliomyelitis, pertussis, and Hib, alongside adult vaccines addressing influenza, booster needs, meningitis, and those required for travel or endemic regions. The Consumer Healthcare portfolio features over-the-counter remedies for common ailments such as allergies, coughs and colds, and pain relief. It also includes products for liver care, general physical and mental wellness, probiotics, digestive health, and nutritional support. Additionally, this segment offers personal care items like daily body lotions, anti-itch products, moisturizing and soothing lotions, body and foot creams, and powders for eczema. Sanofi maintains an active pipeline with numerous pharmaceutical products and vaccines currently undergoing various stages of development. The company has forged strategic alliances, including a collaboration with GlaxoSmithKline for the development of a recombinant Covid-19 vaccine, a research partnership with Stanford University School of Medicine aimed at advancing immunology and inflammation knowledge, and a collaboration and license option agreement with Prellis Biologics, Inc. Founded in 1973 and headquartered in Paris, France, the company operated as Sanofi-Aventis before rebranding to Sanofi in May 2011.
Giá cổ phiếu
$82.81
Đồng bộ lần cuối: 2026-10-21
Vốn hóa thị trường
$99.21B
Thay đổi (1 ngày)
-5.12%
Thay đổi (1 năm)
-17.03%
Quốc gia
FR
Giao dịch Sanofi (SAN)
Danh mục
Healthcare
Lịch sử giá cổ phiếu của Sanofi (SAN)
Giá đóng cửa cao nhất: $79.03 vào 2026-10-01
Giá đóng cửa thấp nhất: $58.60 vào 2003-06-01
Giá đóng cửa thấp nhất: $58.60 vào 2003-06-01
Lịch sử giá cổ phiếu của Sanofi từ 2003 đến 2026
Hiệu suất giá cổ phiếu hàng năm
| Năm | Hiệu suất |
|---|---|
| 2026 (TTM) | -6.25% |
| 2025 | 1.01% |
| 2024 | 0.14% |
| 2023 | 1.54% |
| 2022 | -2.77% |
| 2021 | -0.01% |
| 2020 | 0.38% |
| 2019 | 11.68% |
| 2018 | 0.33% |
| 2017 | 8.31% |
| 2016 | -7.29% |
| 2015 | -7.13% |
| 2014 | -9.87% |
| 2013 | 9.73% |
| 2012 | 31.95% |
| 2011 | 10.20% |
| 2010 | -16.92% |
| 2009 | 30.14% |
| 2008 | -36.18% |
| 2007 | 1.96% |
| 2006 | 6.71% |
| 2005 | 11.55% |
| 2004 | 9.82% |
| 2003 | 0.00% |
Giá cổ phiếu của các công ty hoặc đối thủ tương tự
| Công ty | Giá cổ phiếu | Thay đổi 1năm% | Quốc gia |
|---|---|---|---|
| $1.27K | 56.64% |
US
|
|
| $257.61 | 33.52% |
US
|
|
| $284.48 | 24.40% |
US
|
|
| $149.84 | 71.03% |
US
|
|
| $482.98 | 31.03% |
CH
|
